Chlorpromazine Hydrochloride is the first antipsychotic introduced into clinical practice, a phenothiazine dopamine D2-receptor antagonist with additional adrenergic, muscarinic and H1-receptor blocking activity, used for schizophrenia, mania and intractable hiccup. Simson Pharma's Chlorpromazine Hydrochloride reference standard and impurities support compendial testing for this foundational antipsychotic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Chlorpromazine Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.